Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

62.62
BATS BZX Real-Time Price
As of 1:43pm ET
 -0.39 / -0.62%
Today’s Change
47.97
Today|||52-Week Range
64.00
+18.55%
Year-to-Date
Bristol-Myers Squibb misses mark with cancer drug
8:42am / FT.com - Paid Partner Content
US Stocks Lower Friday With Hawkish Tone From Fed
Aug 26 / GuruFocus News - Paid Partner Content
Intermediate Trade: Merck
7:36am / TheStreet.com - Paid Partner Content
Pharmaceuticals are the New Bonds
Aug 26 / GuruFocus News - Paid Partner Content
Cramer: The 'Just You Wait' Crowd Keeps Waiting
Aug 29 / TheStreet.com - Paid Partner Content
Tight Trading on Thursday with Stocks Ending Lower
Aug 25 / GuruFocus News - Paid Partner Content
Gilead Was Smart to Let Medivation Slip Through its Fingers
Aug 29 / GuruFocus News - Paid Partner Content
3 Reasons Gilead Sciences Inc. Stock Could Fall
Aug 25 / MotleyFool.com - Paid Partner Content
The EpiPen Scandal Is Worse Than You Think: What Youre Not Being Told
Aug 27 / Investing Channel - Paid Partner Content
Healthcare Drug Pricing a Factor for the Market on Wednesday
Aug 24 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close63.01
Today’s open62.96
Day’s range62.61 - 63.03
Volume172,361
Average volume (3 months)9,397,977
Market cap$174.2B
Dividend yield2.94%
Data as of 1:43pm ET, 08/30/2016

Growth & Valuation

Earnings growth (last year)-61.67%
Earnings growth (this year)+4.25%
Earnings growth (next 5 years)+6.10%
Revenue growth (last year)-7.92%
P/E ratio34.4
Price/Sales3.87
Price/Book3.92

Competitors

 Today’s
change
Today’s
% change
AGNPRAAllergan plc-0.95-0.11%
NVSNovartis-0.23-0.29%
PFEPfizer-0.18-0.51%
GSKGlaxoSmithKline-0.19-0.44%
Data as of 1:43pm ET, 08/30/2016

Financials

Next reporting dateOctober 25, 2016
EPS forecast (this quarter)$0.98
Annual revenue (last year)$38.8B
Annual profit (last year)$4.4B
Net profit margin11.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
Kenneth C. Frazier
Chief Financial Officer &
Executive Vice President
Robert M. Davis
Corporate headquarters
Kenilworth, New Jersey

Forecasts

Search for Jobs